These results were confirmed in cancer (and non-cancer) cells transiently overexpressing exogenous human SOCS5 (Supplementary Fig. 8e), echoing prior reports in which SOCS5 was described to inhibit STAT6 activation in dendritic cells39 or in T helper (Th) subsets40. The gene discussed is SOCS5; the disease is cancer.